228 filings
8-K
KALV
KalVista Pharmaceuticals Inc
11 Mar 24
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
4:37pm
10-Q
2024 Q3
KALV
KalVista Pharmaceuticals Inc
Quarterly report
11 Mar 24
4:26pm
8-K
KALV
KalVista Pharmaceuticals Inc
7 Mar 24
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
6:38am
8-K
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
424B5
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
Prospectus supplement for primary offering
4:29pm
424B5
wiy4u8chvu8 vsq
14 Feb 24
Prospectus supplement for primary offering
5:13pm
8-K
zazrx z8jdey93kkv3vy
14 Feb 24
Termination of a Material Definitive Agreement
4:14pm
8-K
kgllf
13 Feb 24
Regulation FD Disclosure
6:55am
S-8
xqog2jh7ra cqo2
9 Jan 24
Registration of securities for employees
4:24pm
8-K
pkkhp0 p5ff89ll
7 Dec 23
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
4:17pm
8-K
itr3ibj
28 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
hbepwktdid
7 Sep 23
KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update
4:35pm
ARS
dgjfd9 objwd0z
14 Aug 23
Annual report to shareholders
4:17pm
DEFA14A
v0cx gk48fe
14 Aug 23
Additional proxy soliciting materials
4:11pm
8-K
3yjwz 2u1jyak6
7 Jul 23
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
7:10pm